Literature DB >> 8343504

NMR solution structure of human parathyroid hormone(1-34).

J A Barden1, B E Kemp.   

Abstract

The aqueous solution structure of the biologically-active N-terminal domain of human parathyroid hormone (residues 1-34) was studied by two-dimensional proton nuclear magnetic resonance (2D NMR) spectroscopy, distance geometry, and dynamic simulated annealing. Unambiguous NMR assignments of all backbone and side chain hydrogens were made with the aid of totally correlated spectroscopy experiments, which provided through-bond 1H-1H connectivities, and nuclear Overhauser effect spectroscopy, which provided through-space and sequential backbone connectivities. The NMR data acquired were utilized in a distance geometry algorithm to generate a family of structures which were then refined using dynamic simulated annealing. The major structural feature evident is alpha-helix extending from residues Glu4 to Lys13 and from Val21 to Gln29 with a turn incorporating Asn16-Glu19 resulting in a quite globular C-terminal domain with a hydrophobic core comprising Leu15, Leu18, Trp23, and Val31. Structure-activity studies are interpreted in terms of the deduced conformation of the PTH structure with particular reference to the likely PTH receptor binding site formed primarily by the bulk of the C-terminal helix.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343504     DOI: 10.1021/bi00079a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  The use of N-terminal immobilization of PTH(1-34) on PLGA to enhance bioactivity.

Authors:  Jessica L Sharon; David A Puleo
Journal:  Biomaterials       Date:  2008-04-29       Impact factor: 12.479

4.  Molecular recognition of parathyroid hormone by its G protein-coupled receptor.

Authors:  Augen A Pioszak; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

5.  Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.

Authors:  Tim J Kamerzell; Sangeeta B Joshi; Donald McClean; Lori Peplinskie; Karen Toney; Damon Papac; Meili Li; C Russell Middaugh
Journal:  Protein Sci       Date:  2007-06       Impact factor: 6.725

6.  Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.

Authors:  Seung Rim Hwang; Dong-Hyun Seo; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.